| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/25/2013 | US20130101583 Etanercept Formulations Stabilized with Sodium Chloride |
| 04/25/2013 | US20130101582 Tiki1 and Tiki2, Wnt Inhibitors |
| 04/25/2013 | US20130101580 Compositions and methods for prolonging lifespan |
| 04/25/2013 | US20130101577 Extended Soluble PH20 Polypeptides and uses thereof |
| 04/25/2013 | US20130101551 Induction of IL-12 using immunotherapy |
| 04/25/2013 | US20130101519 Diagnostic Method for Atherosclerosis |
| 04/25/2013 | DE112011102355T5 Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von funktionellen Erkrankungen oder Zuständen des Gastrointestinaltraktes A pharmaceutical combination composition and methods for the treatment of functional disorders or conditions of the gastrointestinal tract |
| 04/25/2013 | CA2852967A1 Antigen presenting cancer vaccine |
| 04/25/2013 | CA2852857A1 Adjuvanted influenza b virus vaccines for pediatric priming |
| 04/25/2013 | CA2852684A1 Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes |
| 04/25/2013 | CA2852474A1 Antibodies directed against influenza |
| 04/25/2013 | CA2851771A1 Modulation of macrophage activation |
| 04/25/2013 | CA2851658A1 Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens |
| 04/25/2013 | CA2850572A1 Stable multiple antigen-binding antibody |
| 04/25/2013 | CA2850245A1 Pd-l1 based immunotherapy |
| 04/24/2013 | EP2584043A2 Anti-glypican 3 antibody having improved kinetics in plasma |
| 04/24/2013 | EP2583981A2 Antibodies and related molecules that bind to PSCA proteins |
| 04/24/2013 | EP2583980A1 Antibodies directed against the alpha chain of IL7 receptor - their use for the preparation of drug candidates |
| 04/24/2013 | EP2583976A2 Peptide vaccines with SEQ ID NO: 210, 196, 202, 213, 214, 214 or 223 for cancers expressing tumor-associated antigens |
| 04/24/2013 | EP2583688A1 Multi-CBV vaccine for preventing or treating type 1 diabetes |
| 04/24/2013 | EP2583685A1 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 04/24/2013 | EP2582796A2 Modified parvovirus having enhanced anti-tumour efficacy |
| 04/24/2013 | EP2582729A1 Anti-axl antibodies and methods of use |
| 04/24/2013 | EP2582727A1 Antibodies to endoplasmin and their use |
| 04/24/2013 | EP2582726A1 Antibody derivatives |
| 04/24/2013 | EP2582725A2 Anti-dr4 agonist antibodies |
| 04/24/2013 | EP2582724A2 Anti-human equilibrative nucleoside transporter 1 (hent1) antibodies and methods of use thereof |
| 04/24/2013 | EP2582722A2 Anti-gd2 antibodies |
| 04/24/2013 | EP2582721A1 Antibodies useful in passive influenza immuization |
| 04/24/2013 | EP2582394A1 Stabilised human immunoglobulin composition |
| 04/24/2013 | EP2582393A1 Dose selection of adjuvanted synthetic nanocarriers |
| 04/24/2013 | EP2582392A2 Use of b lymphocyte stimulator protein antagonists to treat asthma and other allergic and inflammatory conditions of the respiratory system |
| 04/24/2013 | EP2582391A2 Arthritis treatment |
| 04/24/2013 | EP2582390A1 Immunotherapeutic method involving cd123 (il-3r ) antibodies and immunostimulating complex |
| 04/24/2013 | EP2582389A2 High affinity human antibodies to human cytomegalovirus (cmv) gb protein |
| 04/24/2013 | EP2582388A2 Detection of epha3 as a marker of the presence of a solid tumor |
| 04/24/2013 | EP2582375A2 Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease |
| 04/24/2013 | EP2395022A9 LINGO binding molecules and pharmaceutical use thereof |
| 04/24/2013 | CN1976724B Meningococcal conjugate vaccination |
| 04/24/2013 | CN1758923B Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria |
| 04/24/2013 | CN1520303B Turnor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 04/24/2013 | CN103068985A Pan-lyssavirus vaccines against rabies |
| 04/24/2013 | CN103068984A Production of hemagglutinin-neuraminidase protein in microalgae |
| 04/24/2013 | CN103068851A Antibodies to endoplasmin and their use |
| 04/24/2013 | CN103068850A Single -chain variable fragment anti-cd133 antibodies and uses thereof |
| 04/24/2013 | CN103068849A Anti-bv8 antibodies and uses thereof |
| 04/24/2013 | CN103068848A Anti-n3pglu amyloid beta peptide antibodies and uses thereof |
| 04/24/2013 | CN103068838A Vaccine against streptococcal infections based on recombinant proteins |
| 04/24/2013 | CN103068837A Chimeric momp antigen, method and use |
| 04/24/2013 | CN103068836A 癌症疫苗 Cancer vaccine |
| 04/24/2013 | CN103068396A A method for inhibiting alternative pathway mediated disorders with anti-properdin antibodies that inhibit c5 interactions with properdin |
| 04/24/2013 | CN103060343A Duck plague virus g E protein genes and application thereof |
| 04/24/2013 | CN103060278A Asia 1 type foot and mouth disease virus acid resistant mutant strains, capsid protein carried by same and encoding gene thereof and application |
| 04/24/2013 | CN103060274A RANKL-TNF sample region mouse monoclonal antibody and its preparation method and use |
| 04/24/2013 | CN103060221A Culture medium adopting continuous enrichment culture for mycoplasma gaujseptium and preparation method |
| 04/24/2013 | CN103060220A Low-serum culture medium for efficiently culturing mycoplasma hyopneumoniae and preparation method thereof |
| 04/24/2013 | CN103059295A Hydrophobic-modified polyethyleneimine and application thereof as protein carrier |
| 04/24/2013 | CN103059142A Recombinant protein of antigen to porcine circovirus and antigen to porcine reproductive and respiratory syndrome virus, and preparation method and application of recombinant protein |
| 04/24/2013 | CN103059140A Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in treatment of allergies |
| 04/24/2013 | CN103059139A Methicillin-resistant Staphylococcus aureus (MRSA) vaccine recombinant proteantigen I12C, and preparation method and application thereof |
| 04/24/2013 | CN103059138A Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics |
| 04/24/2013 | CN103059137A Preparation and application of human interleukin-6 receptor (hIL6R)-resistant antibody with high affinity |
| 04/24/2013 | CN103059133A Monoclonal antibody and antibody composition for neutralizing canine distemper virus (CDV) |
| 04/24/2013 | CN103059120A Dust mite allergens Derf26 and Derf27 and genes and application thereof |
| 04/24/2013 | CN103059119A Dust mite allergen Derf28 and genes and application thereof |
| 04/24/2013 | CN103059104A Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules |
| 04/24/2013 | CN103059103A Specific CD4+T cell epitope peptide of Hantaan virus nucleoprotein |
| 04/24/2013 | CN103055311A Infectious laryngotracheitis mucosa vaccine, as well as preparation method and application thereof |
| 04/24/2013 | CN103055310A Bigeminal inactivated vaccine for avian influenza (H9 sub type) and Escherichia coli and preparation method thereof |
| 04/24/2013 | CN103055309A Freezing and drying protective agent used for infectious bronchitis virus HI antigen and application of freezing and drying protective agent in preparation of HI antigen |
| 04/24/2013 | CN103055308A Male DNA (Deoxyribonucleic Acid) contraceptive vaccine |
| 04/24/2013 | CN103054805A Preparation method and application of injection for needle-free injection |
| 04/24/2013 | CN102337268B Human CTRP4 gene, its coding protein and their application |
| 04/24/2013 | CN102335422B Recombinant phage peculiar smell removal vaccine for boars |
| 04/24/2013 | CN102311928B Recombinant yeast engineering strain coexpressed by proteins of chicken anaemia viruses VP1 and VP2, construction method thereof and application thereof |
| 04/24/2013 | CN102276700B Swine hepatitis E virus antigen epitope and application thereof |
| 04/24/2013 | CN102268078B Swine hepatitis E virus antigen epitope and application thereof |
| 04/24/2013 | CN102240404B Vibrio harveyi DNA vaccine and its construction method and application |
| 04/24/2013 | CN102228686B Process for preparing veterinary rabies inactivated and freeze-dried vaccine through suspension culture cell |
| 04/24/2013 | CN102188704B Methods of treating cancer using IL-21 and monoclonal antibody therapy |
| 04/24/2013 | CN102174091B Truncated and expressed duck plague virus (DPV) recombinant envelope gI protein and preparation method and application thereof |
| 04/24/2013 | CN102021149B Gene NSI deficit type respiratory syncytial virus and application thereof in treating lung cancer |
| 04/24/2013 | CN101985468B SJ16 recombinant protein and application thereof in preparing schistosomiasis vaccine, diagnostic reagent and therapeutic drug |
| 04/24/2013 | CN101905018B Recombinant fusion protein vaccine and attenuated live vector vaccine for treating and preventing helicobacter pylori (Hp) infection |
| 04/24/2013 | CN101861387B Novel bacteriophage and antibacterial composition containing the same |
| 04/24/2013 | CN101730546B Adjuvant combinations of nkt activator, cd40 agonist, and optional antigen, the use through inducing synergistic cellular immunity |
| 04/24/2013 | CN101678095B Novel neutralizing immunogen (nimiv) of rhinovirus and its use for vaccine applications |
| 04/24/2013 | CN101641115B Epha3 antibodies for the treatment of solid tumors |
| 04/24/2013 | CN101537015B Application of carbon nano-tubes in immunity accelerators for preparing anti-tumor immunotherapy medicaments |
| 04/24/2013 | CN101410519B Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 04/24/2013 | CN101410413B Anti-EPHRINB2 antiboies and methods using same |
| 04/24/2013 | CN101355936B Combinations comprising a CDK inhibitor and a growth factor antibody or anti-mitotic |
| 04/24/2013 | CN101300346B Novel biological substance nesfatin and its related substances and uses thereof |
| 04/24/2013 | CN101287490B Vaccination against dengue virus infection |
| 04/24/2013 | CN101208103B 免疫原性组合物 The immunogenic composition |
| 04/24/2013 | CN101184776B Novel anti-plgf antibody |
| 04/24/2013 | CN101133163B Isolated chimeric proteins of modified lumazine synthase |
| 04/24/2013 | CN101128598B Methods of producing influenza vaccine compositions |
| 04/23/2013 | US8426575 N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
| 04/23/2013 | US8426574 Identification of astrovirus VA1 associated with gastroenteritis in humans |